Skip to content

A clinical trial to study the effects of â??De-bloatâ?? capsules in female patients facing stomach discomfort and bloating.

A study to evaluate the effects of â??De-bloatâ?? capsules on Asian women subjects between the age of 25-40 years facing stomach discomfort and bloating.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047380
Enrollment
83
Registered
2022-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: De/bloat Capsule: 2 Capsules twice a day orally for a duration of 7 days Control Intervention1: Not Applicable: Not Applicable

Sponsors

MOOM HEALTH PTE LTD
Lead Sponsor
Spectrum Clinical Research Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Female participants with Age between 25-40 years. 2 Females having regular menstrual cycle. 3 Subjects experiencing bloating after a heavy meal. 4 Females having bloating during their periods. 5 Willing to participate in the study after informed consent

Exclusion criteria

Exclusion criteria: Subject should not be on antacids, NSAIDs or herbal/ ayurvedic medicine 2. Any subject who are taking any medication for bloating in the preceding week. 3. Pregnant or lactating mother 4. Subject with life threatening cardiac, renal, pulmonary or cardiovascular disease. 5. Severe disease requiring hospitalization /steroids /anti-cytokine Therapy. 6. Subject taking antiplatelet drugs. 7. Subject with uncontrolled diabetes. 8. Subject with gall stone disease.

Design outcomes

Primary

MeasureTime frame
Time to get relief from bloating symptoms such asborborygmus, eructation, early satiety, frequencies of defecation etc.This can also be relief from post food bloating or PMS bloating. Improvement in quality of lifeTimepoint: Visit 1 visit 2 visit3

Secondary

MeasureTime frame
Improvement in quality of lifeTimepoint: Visit 1 visit 2 visit 3

Countries

India

Contacts

Public ContactDr Viral Shah

Spectrum Clinical Research Pvt Ltd

vshah@spectrumcr.com912240645100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026